The Chondrosarcoma Foundation will host its Second Annual 5k Walk / Run to support research for Chondrosarcoma on October 15, 2022. We are honoring the legacy of Shayna Elise Kramer who lost her battle to chondrosarcoma at the young age of 28. Shayna wanted to advocate for all patient’s suffering from this rare bone cancer. [...]
On September 26, in England Ricky Ashman is raising £500 to Ricky by jumping a 15000ft sky dive to raise money and awareness for the Chondrosarcoma Foundation. I am doing a skydive to raise money for the Chondrosarcoma Foundation. It is a cause close to me because my Mum has suffered this rare form of [...]
William Cross, Ph.D. our board member from the UCL Cancer Center in London has been gracious enough to share his recently published article on: A genetic model for central chondrosarcoma evolution correlates with patient outcome It is William’s hope that others will emulate and replicate the study and in time we can begin testing and [...]
The Chondrosarcoma Foundation will host its Second Annual 5k Walk / Run to support research for Chondrosarcoma on October 15, 2022. We are honoring the legacy of Shayna Elise Kramer who lost her battle to chondrosarcoma at the young age of 28. Shayna wanted to advocate for all patient’s suffering from this rare bone cancer. [...]
By Andrew Gregory Health editor The Guardian 2 days ago A new cancer treatment can stop the disease advancing in patients who are resistant to immunotherapy, doctors have discovered. Immunotherapy uses the immune system to target and kill cancer cells, and can save lives when other treatment options, such as surgery, radiotherapy or chemotherapy, have [...]
Emmanuelle David,Pierre Guihard,Bénédicte Brounais,Anne Riet,Céline Charrier,Séverine Battaglia,François Gouin,Stéphanie Ponsolle,Ronan Le Bot,Carl D. Richards … See all authors First published: 15 November 2010 https://doi.org/10.1002/ijc.25776 Citations: 27Abstract ABSTRACT The cytokine Oncostatin M (OSM) is cytostatic, pro-apoptotic and induces differentiation of osteosarcoma cells into osteocytes, suggesting new adjuvant treatment for these bone-forming sarcomas. However, OSM systemic over-expression could [...]
Jamie Elliott a Chondrosarcoma Warrior extraordinaire. She is featured in this months Brighter Magazine for women who live their life with cancer. Jamie shows her spirit and how she overcomes obstacles by wining Pickleball Championships. Jamie is a winner, in pickleball and in life and is an inspiration to all. For more information: Brighter Magazine [...]
A new Phase 1 Immunotherapy trial using genetic sequencing to address patients with metastatic solid tumors.
Today is Stanley Tono Cornejo’s 50th Birthday. Please send good wishes and prayers to his family.
Inhibrx submitted the attached poster at the American Society of Clinical Oncology ASCO Conference last month. It addresses the Phase 2 study and the locations where they plan to have their our pivotal study for the medication INBRX-109. The best place for Chondrosarcoma patients to reach out to is to go to clinicaltrials which is [...]